Dynamic microPET imaging of ultrasound contrast agents and lipid delivery

Michaelann S. Tartis, Dustin E. Kruse, Hairong Zheng, Hua Zhang, Azadeh Kheirolomoom, Jan Marik, Katherine W. Ferrara

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Interest in ultrasound contrast agents (lipid-shelled microbubbles) as delivery vehicles is increasing; however, the biodistribution of these agents remains uncharacterized, both with and without ultrasound. In this study, an 18F-labeled lipid ([18F]fluorodipalmitin), incorporated in microbubble shells, was used as a dynamic microPET probe for quantitative 90-minute biodistribution measurements in male Fischer 344 rats (n = 2). The spleen retained the highest concentration of radioactive lipid at ~ 2.6%-injected dose per cubic centimeter (% ID/cc) and the liver demonstrated the largest total accumulation (~ 17% ID). The microbubble pharmacokinetic profile differed from free lipid, which is rapidly cleared from blood, and liposomes, which remain in circulation. Additionally, region of interest (ROI) analysis over 60 minutes (post-ultrasound treatment) quantified the delivery of lipid by therapeutic ultrasound from microbubbles to kidney tissue (n = 8). The ultrasound sequence consisted of a 200 kPa, 5.3 MHz radiation force pulse followed by a 1.6 MPa, 1.4 MHz fragmentation pulse and was applied to one kidney, while the contralateral kidney served as a control. ROI-estimated activity in treated kidneys was slightly but significantly greater at 0 and 60 min than in untreated kidneys (p = 0.0012 and 0.0035, respectively). This effect increased with the number of microbubbles injected (p = 0.006). In summary, [18F]fluorodipalmitin was used to characterize the biodistribution of contrast microbubble shells and the deposition of lipid was shown to be locally increased after insonation.

Original languageEnglish (US)
Pages (from-to)160-166
Number of pages7
JournalJournal of Controlled Release
Volume131
Issue number3
DOIs
StatePublished - Nov 12 2008

Fingerprint

Microbubbles
Contrast Media
Ultrasonography
Lipids
Kidney
Inbred F344 Rats
Liposomes
Spleen
Pharmacokinetics
Radiation
Liver
Therapeutics

Keywords

  • [F]fluorodipalmitin ([F]FDP)
  • MicroPET
  • Targeted drug delivery
  • Therapeutic ultrasound
  • Ultrasound contrast agents

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Tartis, M. S., Kruse, D. E., Zheng, H., Zhang, H., Kheirolomoom, A., Marik, J., & Ferrara, K. W. (2008). Dynamic microPET imaging of ultrasound contrast agents and lipid delivery. Journal of Controlled Release, 131(3), 160-166. https://doi.org/10.1016/j.jconrel.2008.07.030

Dynamic microPET imaging of ultrasound contrast agents and lipid delivery. / Tartis, Michaelann S.; Kruse, Dustin E.; Zheng, Hairong; Zhang, Hua; Kheirolomoom, Azadeh; Marik, Jan; Ferrara, Katherine W.

In: Journal of Controlled Release, Vol. 131, No. 3, 12.11.2008, p. 160-166.

Research output: Contribution to journalArticle

Tartis, MS, Kruse, DE, Zheng, H, Zhang, H, Kheirolomoom, A, Marik, J & Ferrara, KW 2008, 'Dynamic microPET imaging of ultrasound contrast agents and lipid delivery', Journal of Controlled Release, vol. 131, no. 3, pp. 160-166. https://doi.org/10.1016/j.jconrel.2008.07.030
Tartis MS, Kruse DE, Zheng H, Zhang H, Kheirolomoom A, Marik J et al. Dynamic microPET imaging of ultrasound contrast agents and lipid delivery. Journal of Controlled Release. 2008 Nov 12;131(3):160-166. https://doi.org/10.1016/j.jconrel.2008.07.030
Tartis, Michaelann S. ; Kruse, Dustin E. ; Zheng, Hairong ; Zhang, Hua ; Kheirolomoom, Azadeh ; Marik, Jan ; Ferrara, Katherine W. / Dynamic microPET imaging of ultrasound contrast agents and lipid delivery. In: Journal of Controlled Release. 2008 ; Vol. 131, No. 3. pp. 160-166.
@article{c4480e6f684d4e42bae9267362b6647a,
title = "Dynamic microPET imaging of ultrasound contrast agents and lipid delivery",
abstract = "Interest in ultrasound contrast agents (lipid-shelled microbubbles) as delivery vehicles is increasing; however, the biodistribution of these agents remains uncharacterized, both with and without ultrasound. In this study, an 18F-labeled lipid ([18F]fluorodipalmitin), incorporated in microbubble shells, was used as a dynamic microPET probe for quantitative 90-minute biodistribution measurements in male Fischer 344 rats (n = 2). The spleen retained the highest concentration of radioactive lipid at ~ 2.6{\%}-injected dose per cubic centimeter ({\%} ID/cc) and the liver demonstrated the largest total accumulation (~ 17{\%} ID). The microbubble pharmacokinetic profile differed from free lipid, which is rapidly cleared from blood, and liposomes, which remain in circulation. Additionally, region of interest (ROI) analysis over 60 minutes (post-ultrasound treatment) quantified the delivery of lipid by therapeutic ultrasound from microbubbles to kidney tissue (n = 8). The ultrasound sequence consisted of a 200 kPa, 5.3 MHz radiation force pulse followed by a 1.6 MPa, 1.4 MHz fragmentation pulse and was applied to one kidney, while the contralateral kidney served as a control. ROI-estimated activity in treated kidneys was slightly but significantly greater at 0 and 60 min than in untreated kidneys (p = 0.0012 and 0.0035, respectively). This effect increased with the number of microbubbles injected (p = 0.006). In summary, [18F]fluorodipalmitin was used to characterize the biodistribution of contrast microbubble shells and the deposition of lipid was shown to be locally increased after insonation.",
keywords = "[F]fluorodipalmitin ([F]FDP), MicroPET, Targeted drug delivery, Therapeutic ultrasound, Ultrasound contrast agents",
author = "Tartis, {Michaelann S.} and Kruse, {Dustin E.} and Hairong Zheng and Hua Zhang and Azadeh Kheirolomoom and Jan Marik and Ferrara, {Katherine W.}",
year = "2008",
month = "11",
day = "12",
doi = "10.1016/j.jconrel.2008.07.030",
language = "English (US)",
volume = "131",
pages = "160--166",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Dynamic microPET imaging of ultrasound contrast agents and lipid delivery

AU - Tartis, Michaelann S.

AU - Kruse, Dustin E.

AU - Zheng, Hairong

AU - Zhang, Hua

AU - Kheirolomoom, Azadeh

AU - Marik, Jan

AU - Ferrara, Katherine W.

PY - 2008/11/12

Y1 - 2008/11/12

N2 - Interest in ultrasound contrast agents (lipid-shelled microbubbles) as delivery vehicles is increasing; however, the biodistribution of these agents remains uncharacterized, both with and without ultrasound. In this study, an 18F-labeled lipid ([18F]fluorodipalmitin), incorporated in microbubble shells, was used as a dynamic microPET probe for quantitative 90-minute biodistribution measurements in male Fischer 344 rats (n = 2). The spleen retained the highest concentration of radioactive lipid at ~ 2.6%-injected dose per cubic centimeter (% ID/cc) and the liver demonstrated the largest total accumulation (~ 17% ID). The microbubble pharmacokinetic profile differed from free lipid, which is rapidly cleared from blood, and liposomes, which remain in circulation. Additionally, region of interest (ROI) analysis over 60 minutes (post-ultrasound treatment) quantified the delivery of lipid by therapeutic ultrasound from microbubbles to kidney tissue (n = 8). The ultrasound sequence consisted of a 200 kPa, 5.3 MHz radiation force pulse followed by a 1.6 MPa, 1.4 MHz fragmentation pulse and was applied to one kidney, while the contralateral kidney served as a control. ROI-estimated activity in treated kidneys was slightly but significantly greater at 0 and 60 min than in untreated kidneys (p = 0.0012 and 0.0035, respectively). This effect increased with the number of microbubbles injected (p = 0.006). In summary, [18F]fluorodipalmitin was used to characterize the biodistribution of contrast microbubble shells and the deposition of lipid was shown to be locally increased after insonation.

AB - Interest in ultrasound contrast agents (lipid-shelled microbubbles) as delivery vehicles is increasing; however, the biodistribution of these agents remains uncharacterized, both with and without ultrasound. In this study, an 18F-labeled lipid ([18F]fluorodipalmitin), incorporated in microbubble shells, was used as a dynamic microPET probe for quantitative 90-minute biodistribution measurements in male Fischer 344 rats (n = 2). The spleen retained the highest concentration of radioactive lipid at ~ 2.6%-injected dose per cubic centimeter (% ID/cc) and the liver demonstrated the largest total accumulation (~ 17% ID). The microbubble pharmacokinetic profile differed from free lipid, which is rapidly cleared from blood, and liposomes, which remain in circulation. Additionally, region of interest (ROI) analysis over 60 minutes (post-ultrasound treatment) quantified the delivery of lipid by therapeutic ultrasound from microbubbles to kidney tissue (n = 8). The ultrasound sequence consisted of a 200 kPa, 5.3 MHz radiation force pulse followed by a 1.6 MPa, 1.4 MHz fragmentation pulse and was applied to one kidney, while the contralateral kidney served as a control. ROI-estimated activity in treated kidneys was slightly but significantly greater at 0 and 60 min than in untreated kidneys (p = 0.0012 and 0.0035, respectively). This effect increased with the number of microbubbles injected (p = 0.006). In summary, [18F]fluorodipalmitin was used to characterize the biodistribution of contrast microbubble shells and the deposition of lipid was shown to be locally increased after insonation.

KW - [F]fluorodipalmitin ([F]FDP)

KW - MicroPET

KW - Targeted drug delivery

KW - Therapeutic ultrasound

KW - Ultrasound contrast agents

UR - http://www.scopus.com/inward/record.url?scp=54049084280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54049084280&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2008.07.030

DO - 10.1016/j.jconrel.2008.07.030

M3 - Article

C2 - 18718854

AN - SCOPUS:54049084280

VL - 131

SP - 160

EP - 166

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 3

ER -